Cargando…

Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome

BACKGROUND: The characteristics of polycystic ovary syndrome (PCOS), a common reproductive endocrinal disorder, are high incidence, complicated aetiology and poor therapeutic effects. PCOS patients frequently exhibit gut dysbiosis; however, its roles in the regulation of metabolic and endocrinal bal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Qixin, Wang, Juan, Li, Weiping, Chen, Zi-Jiang, Du, Yanzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103748/ https://www.ncbi.nlm.nih.gov/pubmed/33957990 http://dx.doi.org/10.1186/s40168-021-01046-5

Ejemplares similares

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
por: Liu, Rui, et al.
Publicado: (2017)

Impact of Chinese Herbal Medicine on Glucolipid Metabolic Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Li, Jie, et al.
Publicado: (2022)

Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity
por: Ma, Linsha, et al.
Publicado: (2020)

Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
por: Liang, Ruining, et al.
Publicado: (2019)

Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome
por: Zhou, Ruiqiong, et al.
Publicado: (2020)

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
por: Sun, Yan, et al.
Publicado: (2023)

Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome
por: Kumar, Amar Nagesh, et al.
Publicado: (2016)

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
por: Li, Na, et al.
Publicado: (2021)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
por: Akın, Leyla, et al.
Publicado: (2020)

Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2017)

Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis
por: Zhu, Wanlong, et al.
Publicado: (2022)

A Rat Model of Maternal Polycystic Ovary Syndrome Shows that Exposure to Androgens In Utero Results in Dysbiosis of the Intestinal Microbiota and Metabolic Disorders of the Newborn Rat
por: Gulan, Tuohetimulati, et al.
Publicado: (2019)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Common endocrine disorders associated with the polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2021)

Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
por: Jing, Tianrui, et al.
Publicado: (2023)

Erythropoietin-producing hepatocellular A7 triggering ovulation indicates a potential beneficial role for polycystic ovary syndrome
por: Li, Shang, et al.
Publicado: (2018)

Time-restricted feeding improves metabolic and endocrine profiles in mice with polycystic ovary syndrome
por: Han, Yan, et al.
Publicado: (2022)

Activating transcription factor 3, glucolipid metabolism, and metabolic diseases
por: Hu, Shuwei, et al.
Publicado: (2022)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2022)

Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
por: Jozkowiak, Malgorzata, et al.
Publicado: (2022)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

Endocrine and glycolipid metabolism characteristics of diminished ovarian reserve in Chinese women with polycystic ovary syndrome
por: Wang, Chaojun, et al.
Publicado: (2020)

Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China
por: Zhao, Hongli, et al.
Publicado: (2018)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
por: Yu, Chuchu, et al.
Publicado: (2023)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
por: Chen, Huize, et al.
Publicado: (2023)

Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice
por: Zhang, Hong, et al.
Publicado: (2023)

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
por: Ding, Haigang, et al.
Publicado: (2021)

Serum Leptin and Ghrelin Levels in Women with Polycystic Ovary Syndrome: Correlation with Anthropometric, Metabolic, and Endocrine Parameters
por: Houjeghani, Shiva, et al.
Publicado: (2012)

Evaluation of Endocrine and Metabolic Changes in Polycystic Ovary Syndrome by Ultrasonic Imaging Features under an Intelligent Algorithm
por: Wei, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_if1e5geim1tigkr8v6a3njb331